Prescription of hypnotics during hospital stay: an epidemiological study in a Swiss hospital

Details

Ressource 1Download: BIB_8119D32BD45B.P001.pdf (628.21 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_8119D32BD45B
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Poster: Summary – with images – on one page of the results of a researche project. The summaries of the poster must be entered in "Abstract" and not "Poster".
Collection
Publications
Title
Prescription of hypnotics during hospital stay: an epidemiological study in a Swiss hospital
Title of the conference
GSASA-Kongress, Gesellschaft Schweizerischer Amt- und Spitalapotheker = Congrès annuel de la GSASA, Société suisse des pharmaciens de l'administration et des hôpitaux
Author(s)
Schumacher L., Dobrinas M., Tagan D., Sautebin A., Widmer N., Blanc A.-L.
Address
Zürich, Switzerland, November 26-27, 2015
Publication state
Published
Issued date
2015
Language
english
Abstract
Background & Objectives: Hypnotics have been associated with many adverse effects, such as drowsiness, confusion, falls and dizziness, especially in elderly population. Moreover, chronic use can cause decreased cognitive performance and addiction. A regional prevention campaign "Hypnotic? Not necessarily needed" conducted in the Canton of Vaud, focused on this topic. This study aims to describe introduction and discharge prescription of hypnotic drugs during stay in an internal medicine ward.
Methods: The study took place in a 70-bed internal medicine department of a Swiss regional hospital for a period of 3 months. Inclusion criteria were: age 18 or more, hospital stay for more than 24 hours, discernment and patient's approval. Demographic data (age, gender, diagnosis, co-morbidity) and medication data (chronic hypnotic use, hypnotic's introduction, day of introduction, drug-related problems, and administrative data) were collected.
Results: 290 patients were included. 73% of them were over 65 years old and 58% were women. 34% had a chronic use of hypnotics before hospital stay and 44% had a prescription for hypnotics after hospital stay. Hypnotics medication were introduced in 37% (n=108) of patients, mostly as required (68%). Half (52%) of hypnotics were prescribed during the first 24 hours of hospital stay and 76% of these introductions were not reassessed during hospital stay. Drugs introduced were: benzodiazepines (47%), clomethiazol (32%), benzodiazepine related drugs (11%; zolpidem, zopiclone) and other hypnotics (10%; herbal drugs, melatonin, antidepressant and antipsychotic). Different hypnotics were used depending on age: lorazepam for people < 65 years old, and clomethiazol for ≥ 65 years old. Drug-drug interactions were detected in 68% of new hypnotic prescription: 87% pharmacodynamic (mutual increase of adverse reactions) and 13% pharmacokinetic (impact on drug disposition). After hospital stay, 37% (n=40) of the patients had a new hypnotic drugs on their discharge prescription compared to their preadmission treatment.
Discussion & Conclusions: Introduction of an hypnotic medication happened in nearly 40% of hospitalized patients. Most of the time, physicians reassessed the new hypnotic on discharges prescriptions, one-third of hypnotics are kept at the end of the hospital stay. These prescriptions may generate chronic use and expose patients to drug-related problem (adverse effects and interactions).
Create date
25/08/2016 10:28
Last modification date
21/08/2019 5:36
Usage data